Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,870
archived clinical trials in
Pain

Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated:  8/18/2014
Pfizer Investigational Site
mi
from
Boardman, OH
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated: 8/18/2014
Pfizer Investigational Site
mi
from
Boardman, OH
Click here to add this to my saved trials
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated:  8/18/2014
Pfizer Investigational Site
mi
from
Cincinnati, OH
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated: 8/18/2014
Pfizer Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated:  8/18/2014
Pfizer Investigational Site
mi
from
Columbus, OH
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated: 8/18/2014
Pfizer Investigational Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated:  8/18/2014
Pfizer Investigational Site
mi
from
Philadelphia, PA
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated: 8/18/2014
Pfizer Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated:  8/18/2014
Pfizer Investigational Site
mi
from
Charleston, SC
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated: 8/18/2014
Pfizer Investigational Site
mi
from
Charleston, SC
Click here to add this to my saved trials
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated:  8/18/2014
Pfizer Investigational Site
mi
from
Myrtle Beach, SC
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated: 8/18/2014
Pfizer Investigational Site
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated:  8/18/2014
Pfizer Investigational Site
mi
from
Salt Lake City, UT
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated: 8/18/2014
Pfizer Investigational Site
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Fenobam on Heat/Capsaicin Induced Hyperalgesia in Healthy Volunteers
A Double Blind, Randomized, Placebo Controlled, Crossover Study to Investigate the Anti-hyperalgesic Efficacy of a Single Dose of Fenobam on Heat/Capsaicin Induced Cutaneous Hyperalgesia in Adult Healthy Volunteers.
Status: Enrolling
Updated:  12/10/2014
Washington University School of Medicine
mi
from
Saint Louis, MO
Fenobam on Heat/Capsaicin Induced Hyperalgesia in Healthy Volunteers
A Double Blind, Randomized, Placebo Controlled, Crossover Study to Investigate the Anti-hyperalgesic Efficacy of a Single Dose of Fenobam on Heat/Capsaicin Induced Cutaneous Hyperalgesia in Adult Healthy Volunteers.
Status: Enrolling
Updated: 12/10/2014
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
The Effectiveness of a Mechanical Manual Therapy Device in the Treatment of Neck Pain
The Effectiveness of a Mechanical Manual Therapy Device in the Treatment of Neck Pain
Status: Enrolling
Updated:  3/17/2015
University of Florida
mi
from
Gainesville, FL
The Effectiveness of a Mechanical Manual Therapy Device in the Treatment of Neck Pain
The Effectiveness of a Mechanical Manual Therapy Device in the Treatment of Neck Pain
Status: Enrolling
Updated: 3/17/2015
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Safety and Efficacy of Cryoablation for Abdominal Pain Associated With Pancreatic Cancer
Percutaneous Cryoablation for the Palliation of Abdominal Pain Associated With Pancreatic Cancer
Status: Enrolling
Updated:  3/17/2015
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Safety and Efficacy of Cryoablation for Abdominal Pain Associated With Pancreatic Cancer
Percutaneous Cryoablation for the Palliation of Abdominal Pain Associated With Pancreatic Cancer
Status: Enrolling
Updated: 3/17/2015
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Safety and Efficacy of Cryoablation for Abdominal Pain Associated With Pancreatic Cancer
Percutaneous Cryoablation for the Palliation of Abdominal Pain Associated With Pancreatic Cancer
Status: Enrolling
Updated:  3/17/2015
The Research Foundation of State University New York
mi
from
Stony Brook, NY
Safety and Efficacy of Cryoablation for Abdominal Pain Associated With Pancreatic Cancer
Percutaneous Cryoablation for the Palliation of Abdominal Pain Associated With Pancreatic Cancer
Status: Enrolling
Updated: 3/17/2015
The Research Foundation of State University New York
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Safety and Efficacy of Cryoablation for Abdominal Pain Associated With Pancreatic Cancer
Percutaneous Cryoablation for the Palliation of Abdominal Pain Associated With Pancreatic Cancer
Status: Enrolling
Updated:  3/17/2015
University Hospitals
mi
from
Cleveland, OH
Safety and Efficacy of Cryoablation for Abdominal Pain Associated With Pancreatic Cancer
Percutaneous Cryoablation for the Palliation of Abdominal Pain Associated With Pancreatic Cancer
Status: Enrolling
Updated: 3/17/2015
University Hospitals
mi
from
Cleveland, OH
Click here to add this to my saved trials
Using Saline for Myofascial Pain Syndromes (USAMPS)
Using Saline for Myofascial Pain Syndromes (USAMPS)
Status: Enrolling
Updated:  6/11/2015
Lyndon Baines Johnson General Hospital
mi
from
Houston, TX
Using Saline for Myofascial Pain Syndromes (USAMPS)
Using Saline for Myofascial Pain Syndromes (USAMPS)
Status: Enrolling
Updated: 6/11/2015
Lyndon Baines Johnson General Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Using Saline for Myofascial Pain Syndromes (USAMPS)
Using Saline for Myofascial Pain Syndromes (USAMPS)
Status: Enrolling
Updated:  6/11/2015
Memorial Hermann Hospital, Texas Medical Center
mi
from
Houston, TX
Using Saline for Myofascial Pain Syndromes (USAMPS)
Using Saline for Myofascial Pain Syndromes (USAMPS)
Status: Enrolling
Updated: 6/11/2015
Memorial Hermann Hospital, Texas Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia
The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia
Status: Enrolling
Updated:  7/21/2015
Cleveland Sleep Research Center
mi
from
Middleburg Heights, OH
The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia
The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia
Status: Enrolling
Updated: 7/21/2015
Cleveland Sleep Research Center
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
Whole Body Hyperthermia Registry Study
Status: Enrolling
Updated:  7/23/2015
University of Arizona
mi
from
Tucson, AZ
Whole Body Hyperthermia Registry Study
Status: Enrolling
Updated: 7/23/2015
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
Whole Body Hyperthermia (WBH) as a Rapid Treatment for Fibromyalgia
Whole Body Hyperthermia (WBH) as a Rapid Treatment for Fibromyalgia
Status: Enrolling
Updated:  7/23/2015
University of Arizona
mi
from
Tucson, AZ
Whole Body Hyperthermia (WBH) as a Rapid Treatment for Fibromyalgia
Whole Body Hyperthermia (WBH) as a Rapid Treatment for Fibromyalgia
Status: Enrolling
Updated: 7/23/2015
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
The Effect of Directional Specific Thoracic Spine Mobilization on Cervical Spine Pain
The Effect of Directional Specific Thoracic Spine Mobilization on Cervial Spine Pain.
Status: Enrolling
Updated:  7/27/2015
Chatham University
mi
from
Pittsburgh, PA
The Effect of Directional Specific Thoracic Spine Mobilization on Cervical Spine Pain
The Effect of Directional Specific Thoracic Spine Mobilization on Cervial Spine Pain.
Status: Enrolling
Updated: 7/27/2015
Chatham University
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Web-Based Program for Symptom Management in Fibromyalgia
Web-Based Program for Symptom Management in Fibromyalgia
Status: Enrolling
Updated:  8/3/2015
Collinge and Associates
mi
from
Eugene, OR
Web-Based Program for Symptom Management in Fibromyalgia
Web-Based Program for Symptom Management in Fibromyalgia
Status: Enrolling
Updated: 8/3/2015
Collinge and Associates
mi
from
Eugene, OR
Click here to add this to my saved trials
The Effect of Intravenous Lidocaine on Allodynia
The Effect of Intravenous Lidocaine on Allodynia (Carl Koller Grant)
Status: Enrolling
Updated:  8/4/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
The Effect of Intravenous Lidocaine on Allodynia
The Effect of Intravenous Lidocaine on Allodynia (Carl Koller Grant)
Status: Enrolling
Updated: 8/4/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Effect of Nitrous Oxide in Treating Neuropathic Pain: A Study in Chronic Low Back Pain Patients
Effect of Nitrous Oxide in Treating Neuropathic Pain: A Pilot Study in Chronic Low Back Pain Patients
Status: Enrolling
Updated:  8/7/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Effect of Nitrous Oxide in Treating Neuropathic Pain: A Study in Chronic Low Back Pain Patients
Effect of Nitrous Oxide in Treating Neuropathic Pain: A Pilot Study in Chronic Low Back Pain Patients
Status: Enrolling
Updated: 8/7/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Effect of Nitrous Oxide in Treating Neuropathic Pain: A Study in Chronic Low Back Pain Patients
Effect of Nitrous Oxide in Treating Neuropathic Pain: A Pilot Study in Chronic Low Back Pain Patients
Status: Enrolling
Updated:  8/7/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Effect of Nitrous Oxide in Treating Neuropathic Pain: A Study in Chronic Low Back Pain Patients
Effect of Nitrous Oxide in Treating Neuropathic Pain: A Pilot Study in Chronic Low Back Pain Patients
Status: Enrolling
Updated: 8/7/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Efficacy of Combination Therapy vs Placebo for Pediatric Functional Abdominal Pain
Efficacy of Combination Therapy vs Placebo for Pediatric Functional Abdominal Pain
Status: Enrolling
Updated:  8/21/2015
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Efficacy of Combination Therapy vs Placebo for Pediatric Functional Abdominal Pain
Efficacy of Combination Therapy vs Placebo for Pediatric Functional Abdominal Pain
Status: Enrolling
Updated: 8/21/2015
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Safety and Efficacy of AGN 203818 for Pain Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated:  8/25/2015
Clinical Research Facility
mi
from
Canton, OH
Safety and Efficacy of AGN 203818 for Pain Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated: 8/25/2015
Clinical Research Facility
mi
from
Canton, OH
Click here to add this to my saved trials
Safety and Efficacy of AGN 203818 for Pain Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated:  8/25/2015
mi
from
Geneva,
Safety and Efficacy of AGN 203818 for Pain Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated: 8/25/2015
mi
from
Geneva,
Click here to add this to my saved trials
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Phoenix, AZ
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Fresno, CA
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Lomita, CA
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Lomita, CA
Click here to add this to my saved trials
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Long Beach, CA
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Pasadena, CA
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Pasadena, CA
Click here to add this to my saved trials
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Ft. Lauderdale, FL
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Ft. Lauderdale, FL
Click here to add this to my saved trials
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Orlando, FL
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Sarasota, FL
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Sarasota, FL
Click here to add this to my saved trials
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Sunrise, FL
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Sunrise, FL
Click here to add this to my saved trials
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Tampa, FL
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Winter Park, FL
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Winter Park, FL
Click here to add this to my saved trials
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Columbus, GA
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Columbus, GA
Click here to add this to my saved trials
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Savannah, GA
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Savannah, GA
Click here to add this to my saved trials
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Bloomington, IL
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Bloomington, IL
Click here to add this to my saved trials
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Chicago, IL
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Evansville, IN
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Overland Park, KA
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Overland Park, KA
Click here to add this to my saved trials
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Brockton, MA
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Brockton, MA
Click here to add this to my saved trials
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Raleigh, NC
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Winston-Salem, NC
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Duncansville, PA
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
San Antonio, TX
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
St. Petersburg, FL
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Lincoln, NE
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Lincoln, NE
Click here to add this to my saved trials